Leuprorelin intranasal - Archimedes/West Pharmaceutical Services

Drug Profile

Leuprorelin intranasal - Archimedes/West Pharmaceutical Services

Alternative Names: leuprorelide intranasal - Archimedes

Latest Information Update: 31 Aug 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Archimedes Pharma; West Pharmaceutical Services
  • Developer Archimedes Pharma
  • Class Antineoplastics; Gonadotropins; Infertility therapies; Oligopeptides; Pituitary hormone releasing hormones
  • Mechanism of Action Gonadotropin releasing hormone stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Endometriosis

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 05 Aug 2014 Archimedes Pharma has been acquired by ProStrakan
  • 30 Apr 2007 Phase-II clinical trials in Endometriosis in the US(Intranasal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top